Market Overview

UPDATE: Stifel Nicolaus Downgrades Towers Watson Following Strong F4Q13 Report

Related TW
Willis Group, Adeptus Health Moving After Stocks Join S&P 500 And S&P SmallCap 600 Respectively
Top Performing Industries For December 29, 2015

In a report published Thursday, Stifel Nicolaus analyst Steven Shui downgraded Towers Watson (NYSE: TW) from Buy to Hold, and removed the $84.00 price target.

In the report, Stifel Nicolaus noted, “TW posted a strong F4Q13, and we are reducing our CY14 estimates very modestly, but we are lowering our rating on the shares of TW from Buy to Hold since the shares are close to our prior $84 target price, and we just don't see enough upside potential over the next 12 months to continue to recommend them at this time. We believe fair value to be about $86-$89 a share, or 14.4x (S&P 500 market multiple) our CY14 EPS estimate of $5.96 ($86 fair value on our current estimate, $89 if we assume much higher share repurchase activity). We were recommending the stock because it was cheap, with a great management team and a story around the Exchange business. Even after yesterday's 5.4% decline (versus S&P 500 decline of 0.5%), at 13.7x CY14 EPS, valuation is close to a market multiple.”

Towers Watson closed on Wednesday at $82.40.

Latest Ratings for TW

Dec 2015Raymond JamesDowngradesOutperformMarket Perform
Aug 2015Deutsche BankMaintainsHold
Jul 2015Stifel NicolausMaintainsBuy

View More Analyst Ratings for TW
View the Latest Analyst Ratings

Posted-In: Steven Shui Stifel NicolausAnalyst Color Downgrades Analyst Ratings


Related Articles (TW)

View Comments and Join the Discussion!